Abstract
Elevation of the serum value of either human chorionic gonadotropin or alpha-fetoprotein in patients with germ cell testicular tumors is often accepted as evidence for persistent malignancy in the absence of histologic confirmation. These laboratory values are not subject to review and confirmation, unlike histologic diagnosis. We report 3 cases in which serum marker values were incorrectly reported to be elevated by commercial laboratories over a thirteen-month period and suggest a method for handling serum samples to avoid errors in diagnosis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 476-478 |
| Number of pages | 3 |
| Journal | Urology |
| Volume | 20 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1982 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Errors in measurement and reporting of serum markers in patients with germ cell tumors. / Kardon, Fredric M.; Krikorian, John G.; Lopez, JoséA; deVere White, Ralph W.
In: Urology, Vol. 20, No. 5, 1982, p. 476-478.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Errors in measurement and reporting of serum markers in patients with germ cell tumors
AU - Kardon, Fredric M.
AU - Krikorian, John G.
AU - Lopez, JoséA
AU - deVere White, Ralph W
PY - 1982
Y1 - 1982
N2 - Elevation of the serum value of either human chorionic gonadotropin or alpha-fetoprotein in patients with germ cell testicular tumors is often accepted as evidence for persistent malignancy in the absence of histologic confirmation. These laboratory values are not subject to review and confirmation, unlike histologic diagnosis. We report 3 cases in which serum marker values were incorrectly reported to be elevated by commercial laboratories over a thirteen-month period and suggest a method for handling serum samples to avoid errors in diagnosis.
AB - Elevation of the serum value of either human chorionic gonadotropin or alpha-fetoprotein in patients with germ cell testicular tumors is often accepted as evidence for persistent malignancy in the absence of histologic confirmation. These laboratory values are not subject to review and confirmation, unlike histologic diagnosis. We report 3 cases in which serum marker values were incorrectly reported to be elevated by commercial laboratories over a thirteen-month period and suggest a method for handling serum samples to avoid errors in diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=0020210493&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020210493&partnerID=8YFLogxK
U2 - 10.1016/0090-4295(82)90116-9
DO - 10.1016/0090-4295(82)90116-9
M3 - Article
VL - 20
SP - 476
EP - 478
JO - Urology
JF - Urology
SN - 1527-9995
IS - 5
ER -